AnaptysBio

+$0.69 (+3.64%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.

CEO
Daniel R. Faga
Employees
102
Headquarters
San Diego, California
Founded
2005

ANAB Key Statistics

Market cap
553.86M
Price-Earnings ratio
—
Dividend yield
—
Average volume
286.18K
High today
$19.75
Low today
$18.24
Open price
$18.90
Volume
234.71K
52 Week high
$37.89
52 Week low
$18.24

ANAB News

BenzingaMay 26

Short Volatility Alert: AnaptysBio, Inc.

On Wednesday, shares of AnaptysBio, Inc. (NASDAQ: ANAB) experienced volatile short activity. After the activity, the stock price went down -3.95% to $19.19. Th
BenzingaMay 24

AnaptysBio's Return On Capital Employed Insights

Benzinga Pro data, AnaptysBio ANAB reported Q1 sales of $970.00 thousand. Earnings fell to a loss of $36.26 million, resulting in a 11.42% decrease from last qu

ANAB Earnings

-$1.31
-$0.02
$1.28
$2.57
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure